Tuesday, September 4, 2018

OncoSec Finds $15M In Investment

San Diego-based cancer immunotherapy developer OncoSec Medical announced this morning that it has raised $15M in an investment in the publicly held company. OncoSec, which is publicly traded on the NASDAQ as ONCS, said it secure the $15M investment from Alpha Holdings, via a strategic investment. The company said the funding is centered on the clinical de

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.